Xilio Therapeutics Inc. (XLO) Live Share Price, Invest From India

Xilio Therapeutics Inc. Stock Performance

as on June 19, 2026 at 6:58 am IST

Day's Low
Day's High
$7.82
Day's Price Range
$9.21
$8.80
11.14%
Downside
4.66%
Upside
52 Week's Low
52 Week's High
$6.47
52-Week Price Range
$12.74
$8.80
26.53%
Downside
44.76%
Upside

Xilio Therapeutics Inc. share price movements today

Previous Close: $8.75
Open: $8.70
Volume: 599.5K
Day's Low - High: $7.82 - $9.21
52 Week Low - High: $6.47 - $12.74

Xilio Therapeutics Inc. Historical Returns

1 Month Return: + 7.36 %
3 Month Return: + 15.13 %
1 Year Return: -5.39 %
3 Year Return: -79.17 %
5 Year Return: 0 %

Xilio Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Xilio Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$55.3M

EPS (TTM)

-3.02

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-40.9M

Revenue (TTM)

53.5M

Profit Margin

-58.52%

Return On Equity TTM

-75.20%

Xilio Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Xilio Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Xilio Therapeutics Inc.	BUY	$55.3M	NA	NA	-58.52%	NA
Alnylam Pharmaceuticals Inc.	BUY	$37.6B	59.83%	71.01	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$115.0B	144.34%	26.88	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$64.4B	13.01%	15.02	29.65%	0.58%

Stock Returns calculator for Xilio Therapeutics Inc. Stock including INR - Dollar returns

The Xilio Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Xilio Therapeutics Inc. investment value today

Current value as on today

₹1,03,823

Returns

₹3,823

(+3.82%)

Returns from Xilio Therapeutics Inc. Stock

-₹4,865 (-4.86%)

Dollar Impact

₹8,688 (+8.69%)

Analyst Recommendation on Xilio Therapeutics Inc. Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Xilio Therapeutics Inc.. Average target price of $20

Xilio Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Xilio Therapeutics Inc..

What analysts predicted

56%UPSIDE

Target Price

$20

Current Price

$8.8

Analyzed by

7 Analysts

Target

$20.00

Xilio Therapeutics Inc. target price $20, a slight upside of 56% compared to current price of $8.8. According to 7 analysts rating.

Indian Investors' Interest in Xilio Therapeutics Inc. Stock

Search interest for Xilio Therapeutics Inc. Stock has decreased by -43% in the last 30 days, reflecting a downward trend in search activity.

Time period: May 20, 2026 to June 19, 2026

Change:-43% versus previous 30 day period

Xilio Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	2	2	2	1	2	8	19	13	12
Gross Profit	0	0	2	2	1	2	-7	19	13	12
Operating Income	-17	-17	-14	-14	-13	-13	-14	-1	-11	-14
EBITDA	-16	-16	-14	-14	-12	-12	-15	-15	10	-9
Interest Expense	0	0	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-16	-17	-13	-14	-13	-13	-15	-16	10	-9
Income Tax Expense	-1	1	-	-	-	-	-	-	-	-
Net Income	-16	-17	-13	-14	-13	-13	-15	-16	10	-9
Net Profit Margin	0.00%	-592.80%	-590.79%	-619.53%	-759.45%	-452.73%	-195.99%	-85.42%	75.70%	-75.34%

Xilio Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	6	43
Gross Profit	0	-1	-1	-1	-1	6	42
Operating Income	-19	-54	-75	-89	-79	-60	-41
EBITDA	-17	-53	-73	-87	-74	-58	-33
Interest Expense	-	0	0	0	0	0	-
Depreciation	0	1	1	1	1	1	1
Income Before Tax	-17	-55	-75	-88	-76	-58	-35
Income Tax Expense	0	0	-1	0	0	-	-
Net Income	-17	-55	-74	-87	-76	-58	-35
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-918.05%	-80.05%

Xilio Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-17	-13	-14	-13	-13	-15	-16	10	-9
Operating Cash Flow	-10	19	-13	-14	28	-14	-17	-1	-22
Investing Cash Flow	-	0	0	0	0	0	-	0	0
Financing Cash Flow	0	20	0	8	4	47	0	35	35
Change in Cash	-9	39	-13	-5	33	32	-17	33	12

Xilio Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-55	-75	-88	-76	-58	-35
Operating Cash Flow	-36	-80	-75	-68	-18	-4
Investing Cash Flow	-2	-1	-1	0	0	0
Financing Cash Flow	10	260	0	-6	29	87
Change in Cash	-28	178	-77	-75	10	82

Global Institutional Holdings in Xilio Therapeutics Inc.

Funds	Holdings
XTX Topco Ltd	0.14%
LPL Financial Corp	0.03%
UBS Group AG	0.06%
Sio Capital Management, LLC	2.32%
Vanguard Capital Management, LLC	1.88%

See all

Insights on Xilio Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, XLO stock has moved up by 9.5%
NO EFFECT
Against Peers
In the last 3 years, Xilio Therapeutics, Inc. Common Stock has experienced a drawdown of -79.2%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 56.8%
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 18.4% return, outperforming this stock by 23.8%

About Xilio Therapeutics Inc.

Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of masked immuno-oncology therapies. The company's pipeline includes XTX501, a bispecific PD-1 / masked IL-2, for patients with metastatic non-small cell lung cancer; Efarindodekin alfa, an investigational, masked IL-12, that is in Phase 2 clinical trial for patients with advanced solid tumors; and Vilastobart, an investigational tumor-activated, Fc-enhanced, high affinity binding anti-CTLA-4 monoclonal antibody. The company was founded in 2016 and is headquartered in Waltham, Massachusetts.

Organisation	Xilio Therapeutics Inc.
Headquarters	828 Winter Street, Waltham, MA, United States, 02451
Industry	Biotechnology
CEO	Dr. Rene Russo BCPS, Pharm.D.
E-voting on shares	Click here to vote

Key Management of Xilio Therapeutics Inc.

Name	Title
Dr. Rene Russo BCPS, Pharm.D.	President, CEO & Director
Mr. Christopher Frankenfield	CFO & COO

FAQs

What is Xilio Therapeutics Inc. share price today?

Xilio Therapeutics Inc. share price today is $8.8 as on June 19, 2026 at 1:28 am IST. Xilio Therapeutics Inc. share today touched a day high of $9.21 and a low of $7.82.

What is the 52 week high and 52 week low for Xilio Therapeutics Inc. share?

Xilio Therapeutics Inc. share touched a 52 week high of $12.74 on September 30, 2025 and a 52 week low of $6.47 on March 12, 2026. Xilio Therapeutics Inc. stock price today i.e. June 19, 2026 at 1:28 am IST is trending at $8.8,which is 30.92% down from its 52 week high and 36.11% up from its 52 week low.

What is Xilio Therapeutics Inc.'s market capitalisation today?

Xilio Therapeutics Inc. market capitalisation is $0.00T as on June 19, 2026 at 1:28 am IST.

How to invest in Xilio Therapeutics Inc. Stock (XLO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Xilio Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Xilio Therapeutics Inc. Shares that will get you 0.1705 shares as per Xilio Therapeutics Inc. share price of $8.8 per share as on June 19, 2026 at 1:28 am IST.

What is the minimum amount required to buy Xilio Therapeutics Inc. Stock (XLO) from India?

Indian investors can start investing in Xilio Therapeutics Inc. (XLO) shares with as little as ₹94.323 or $1 (as of June 19, 2026 at 1:28 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.23 in Xilio Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on June 19, 2026 at 1:28 am IST). Based on Xilio Therapeutics Inc. share’s latest price of $8.8 as on June 19, 2026 at 1:28 am IST, you will get 1.1364 shares of Xilio Therapeutics Inc.. Learn more about fractional shares .